Clinical trial Recruiting at 7 sites Interventional Ages 18 and up

Exercise therapy program for cancer patients

Official title: Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-oriented Exercise Therapy for Oncological Patients

Run by University Hospital Heidelberg · NCT06185777 · Data updated 2026-11-12

This study is testing a new exercise program for cancer patients to see if it helps them recover better by connecting their treatment with local fitness services.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment2500 (estimated)
SponsorUniversity Hospital Heidelberg
Academic / other
Drugs / interventionschemotherapy
Locations7 sites (Freiburg im Breisgau, Baden-Wurttemberg and 6 other locations)
StatusRecruiting
StartedDecember 1, 2023
Main results expectedMarch 1, 2027
Study endsOctober 1, 2027
Registry record updatedFebruary 3, 2025
Trial IDNCT06185777 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this program are cancer patients undergoing chemotherapy, immunotherapy, or radiotherapy who experience symptoms that can be alleviated through exercise.

Probably not a fit

Patients who do not speak German or have been employed in their care provider role for less than six months may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

MOVE-ONKO is focused on creating and implementing a multi-professional care pathway that promotes exercise therapy for cancer patients. This initiative aims to connect oncological care with local exercise therapy services, ensuring that patients have access to quality exercise programs tailored to their needs and side effects. The project will be developed in phases, starting with guideline creation and followed by implementation at seven Comprehensive Cancer Centers in Germany. The ultimate goal is to integrate exercise therapy into standard cancer care, enhancing patient support and recovery.

Why it matters

Potential benefit: If successful, this program could significantly improve the quality of life and recovery outcomes for cancer patients through tailored exercise therapy.

How similar studies have gone: Other studies have shown positive outcomes with exercise therapy for cancer patients, indicating that this approach is both promising and supported by existing evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria (patients):

* cancer patients during chemotherapy, immune therapy or radiotherapy
* having symptoms/side effects that can be effectively treated by exercise (e.g. fatigue) and/or are interested in exercise oncology counseling

Inclusion Criteria (care providers)

\- involved in the implementation process

Exclusion Criteria (both):

\- Insufficient German language skills

Exclusion Criteria (care providers only):

\- Duration employed \<6 months

Where it's running

  • Universitätsklinikum Freiburg
    Freiburg im Breisgau, Baden-Wurttemberg, Germany
    Recruiting
  • Nationales Centrum für Tumorerkrankungen
    Heidelberg, Baden-Wurttemberg, Germany
    Recruiting
  • Medizinische Klinik der Universitätsklinikum Tübingen
    Tübingen, Baden-Wurttemberg, Germany
    Recruiting
  • Universitäres Centrum für Tumorekrankungen Frankfurt
    Frankfurt am Main, Hesse, Germany
    Recruiting
  • Universitäres Centrum für Tumorerkrankungen Mainz
    Mainz, Rhineland-Palatinate, Germany
    Recruiting
  • Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC)
    Dresden, Saxony, Germany
    Recruiting
Show 1 more location
  • Charité - Universitätsmedizin Berlin
    Berlin, State of Berlin, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.